Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Ariel Ramirez-Labrada

8PUBLICATIONS

20CO-AUTHORS

Haematological tumoursPredictive and prognostic markersMolecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jan 13, 2026

Mutant calreticulin enables potent and selective CAR-T cell therapy in preclinical models of myeloproliferative neoplasms.

Cecilia Pesini, Mario Gil-Bellido, Lorena S Millan

|Mar 28, 2025

Combination of exhaled volatile organic compounds with serum biomarkers predicts respiratory infection severity.

Patricia Esteban, Santiago Letona-Gimenez, Maria Pilar Domingo

|Aug 29, 2024

Peripheral Blood TCRβ Repertoire, IL15, IL2 and Soluble Ligands for NKG2D Activating Receptor Predict Efficacy of Immune Checkpoint Inhibitors in Lung Cancer.

Andrea Sesma, Julian Pardo, Dolores Isla

|Jul 22, 2024

In-depth analysis of the interplay between oncogenic mutations and NK cell-mediated cancer surveillance in solid tumors.

Cecilia Pesini, Laura Artal, Jorge Paúl Bernal

|Mar 28, 2024

Biomarkers of Immunotherapy Response in Patients with Non-Small-Cell Lung Cancer: Microbiota Composition, Short-Chain Fatty Acids, and Intestinal Permeability.

Alba Moratiel-Pellitero, María Zapata-García, Marta Gascón-Ruiz

|Jan 21, 2023

A Subset of PD-1-Expressing CD56<sup>bright</sup> NK Cells Identifies Patients with Good Response to Immune Checkpoint Inhibitors in Lung Cancer.

Marta Gascón-Ruiz, Ariel Ramírez-Labrada, Rodrigo Lastra

Pageof 2

Frequent Collaborators

5 joint publications

Eva M Gálvez

5 joint publications

Julián Pardo

4 joint publications

Patricia Esteban

4 joint publications

María Pilar Domingo

2 joint publications

Dolores Isla

2 joint publications

Alfonso Yubero

1 joint publications

Cecilia Pesini

1 joint publications

Maykel A Arias

1 joint publications

Llipsy Santiago

1 joint publications

José Manuel Garcia-Aznar

Frequent Collaborators

5 joint publications

Eva M Gálvez

5 joint publications

Julián Pardo

4 joint publications

Patricia Esteban

4 joint publications

María Pilar Domingo

Top Related Videos

Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells

Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells

Published on : Jan 05, 2018

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on : Aug 14, 2019

See more related videos

Top Related Videos

Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells

Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells

Published on : Jan 05, 2018

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on : Aug 14, 2019

See more related videos